Financial Analysis
DNA Finance has been carrying out buy-side financial analyses thanks to its in-depth knowledge of the healthcare sector.
Through a careful monitoring of stocks in the XBI and NBI indices (medtech, biotech and pharma), we produce analysis of listed companies in the healthcare sector with small, mid and large cap market capitalizations.
Commercial Coverage
In addition to these financial analyses for internal monitoring, DNA Finance offers commercial coverage of companies in the healthcare sector.
This one-off and mandated analysis involves:
- a presentation of the company and its product portfolio;
- an analysis and valuation of its commercialized and pipeline products;
- an analysis of its financial data and its share price.
We offer a global and personalized approach in our analysis.